Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
O-STAT Study: Rosuvastatin and Enoxaparin Thromboprophylaxis in Ovarian Cancer Surgery
NCT03532139Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2018
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in venous thromboembolism (VTE), sponsored by Beth Israel Deaconess Medical Center. Started Jul 2018; status: completed.
02
Drugs
rosuvastatin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03532139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03532139.